Skip to main content
Clinical Trials/CTRI/2018/10/016056
CTRI/2018/10/016056
Not Yet Recruiting
N/A

Cardiopulmonary exercise testing as a predictor of postoperative outcome in patients undergoing esophageal cancer surgery following neoadjuvant chemotherapy

AIIMS0 sites0 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Health Condition 1: C00-D49- Neoplasms
Sponsor
AIIMS
Status
Not Yet Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
AIIMS

Eligibility Criteria

Inclusion Criteria

  • 1\.Age 18\-75 years
  • 2\.ASA I and II
  • 3\.All patients of esophagus cancer (squamous cell carcinoma or adenocarcinoma) of the middle or lower third of esophagus, undergoing neoadjuvant chemotherapy followed by transthoracic McEwans or Ivor lewis esophagectomy.
  • 4\.Patients giving written informed consent

Exclusion Criteria

  • 1\.Contraindications to perform CPET
  • a.Unstable cardiac status (Acute myocardial infarction 3â??5 days, unstable angina, moderate stenotic valvular heart disease, uncontrolled arrhythmias, syncope, active endocarditis, acute myocarditis or pericarditis, hypertrophic cardiomyopathy, uncontrolled heart failure)
  • b.Significant pulmonary hypertension
  • c.Acute pulmonary embolus or pulmonary infarction
  • d.Electrolyte abnormalities
  • e.Thrombosis of lower extremities
  • f.Orthopedic impairment that compromises exercise performance
  • g.Uncontrolled asthma
  • h.Pulmonary oedema
  • i.Room air desaturation at rest \< 85%

Outcomes

Primary Outcomes

Not specified

Similar Trials